Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES)
作者： Erik De Clercq
DOI: 10.1016/S1075-8593(06)05002-7
关键词:
摘要: More than 40 compounds have been formally licensed for clinical use as antiviral drugs, and half of these are used the treatment HIV infections. The others approved therapy herpesvirus (HSV, VZV, CMV), hepadnavirus (HBV), hepacivirus (HCV) myxovirus (influenza, RSV) New in development or under preclinical evaluation, and, again, targeting Yet, quite a number important viral pathogens (i.e. HPV, HCV, hemorrhagic fever viruses) remain need effective and/or improved therapies.
elsevier.com
sci-hub.se 参考文章(372)
J D Connor, F G Hayden, J Lane, C A Sable, Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection. Antiviral Therapy. ,vol. 1, pp. 51- 56 ,(1996)
P. Leyssen, N. Charlier, J. Paeshuyse, E. De Clercq, J. Neyts, Prospects for antiviral therapy. Advances in Virus Research. ,vol. 61, pp. 511- 553 ,(2003) , 10.1016/S0065-3527(03)61014-6
George F Gao, Yu Wai Chen, Jieqing Zhu, Po Tien, Ling Ni, Zhibo Jin, Linqing Zhao, Yuan Qian, Design and characterization of human respiratory syncytial virus entry inhibitors. Antiviral Therapy. ,vol. 10, pp. 833- 840 ,(2005)
Nan Sook Lee, Taikoh Dohjima, Gerhard Bauer, Haitang Li, Ming-Jie Li, Ali Ehsani, Paul Salvaterra, John Rossi, Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nature Biotechnology. ,vol. 20, pp. 500- 505 ,(2002) , 10.1038/NBT0502-500
Elizaveta Padalko, Erik Verbeken, Patrick Matthys, Joeri L Aerts, Erik De Clercq, Johan Neyts, Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice BMC Microbiology. ,vol. 3, pp. 25- 25 ,(2003) , 10.1186/1471-2180-3-25
Joseph B. McCormick, Isabel J. King, Patricia A. Webb, Curtis L. Scribner, Robert B. Craven, Karl M. Johnson, Luanne H. Elliott, Rose Belmont-Williams, Lassa Fever New England Journal of Medicine. ,vol. 314, pp. 20- 26 ,(1986) , 10.1056/NEJM198601023140104
Konrad Stadler, Vega Masignani, Markus Eickmann, Stephan Becker, Sergio Abrignani, Hans-Dieter Klenk, Rino Rappuoli, SARS — beginning to understand a new virus Nature Reviews Microbiology. ,vol. 1, pp. 209- 218 ,(2003) , 10.1038/NRMICRO775
Erik De Clercq, The bicyclam AMD3100 story Nature Reviews Drug Discovery. ,vol. 2, pp. 581- 587 ,(2003) , 10.1038/NRD1134
Nicolas Meeùs, Malou M-Louise Haine, Van Damme A. P. Mardaga. pp. 416- 417 ,(1986)
J E Tomassini, M E Davies, J C Hastings, R Lingham, M Mojena, S L Raghoobar, S B Singh, J S Tkacz, M A Goetz, A Novel Antiviral Agent Which Inhibits the Endonuclease of Influenza Viruses Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 1189- 1193 ,(1996) , 10.1128/AAC.40.5.1189